4254-85-7 Usage
Uses
Used in Pharmaceutical Industry:
1,5-Dihydroxy-pentan-3-one is used as a building block for the synthesis of various pharmaceuticals due to its unique chemical structure and properties, contributing to the development of new drugs and therapeutic agents.
Used in Food Additive Industry:
In the food additive industry, 1,5-Dihydroxy-pentan-3-one is utilized for its ability to enhance flavors and fragrances, improving the sensory experience of food products.
Used in Fragrance Industry:
1,5-Dihydroxy-pentan-3-one is employed as a key component in the creation of fragrances, leveraging its aromatic properties to develop unique scents for various applications.
Used in Cosmetic and Personal Care Industry:
1,5-Dihydroxy-pentan-3-one is used as an ingredient in cosmetic and personal care products for its antioxidant and antimicrobial properties, which contribute to product efficacy and shelf life.
Used in Organic Chemistry:
1,5-Dihydroxy-pentan-3-one is used as a chiral building block in organic chemistry, valuable for the production of enantiomerically pure compounds, which are essential in various chemical and pharmaceutical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 4254-85-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,2,5 and 4 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 4254-85:
(6*4)+(5*2)+(4*5)+(3*4)+(2*8)+(1*5)=87
87 % 10 = 7
So 4254-85-7 is a valid CAS Registry Number.
4254-85-7Relevant academic research and scientific papers
A Suite of “Minimalist” Photo-Crosslinkers for Live-Cell Imaging and Chemical Proteomics: Case Study with BRD4 Inhibitors
Pan, Sijun,Jang, Se-Young,Wang, Danyang,Liew, Si Si,Li, Zhengqiu,Lee, Jun-Seok,Yao, Shao Q.
, p. 11816 - 11821 (2017/09/06)
Affinity-based probes (AfBPs) provide a powerful tool for large-scale chemoproteomic studies of drug–target interactions. The development of high-quality probes capable of recapitulating genuine drug–target engagement, however, could be challenging. “Mini
